Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Infectious Disease
•
Infection Prevention and Control
•
Pediatric Oncology
For which pediatric oncology patients do you start bacterial prophylaxis, inpatient or outpatient, and what is your antibiotic of choice?
Related Questions
What infections should we rule out in patients who develop diarrhea on immunotherapy?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
What antibiotic, antifungal and antiviral prophylaxis you give post CAR-T therapy, and what is the duration?
Have you used oral vancomycin as prophylaxis for C difficile infection in patients admitted for allogeneic hematopoietic cell transplant?
Which biomarkers or diagnostic tools do you prioritize to support the decision to start antifungal treatment in septic patients with no clear source of infection but at high risk for fungal infections?
What are your top takeaways from ID Week 2024?
Under what circumstances do you consider valacyclovir for the management of VZV disease of the CNS?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?